A MULTIPLE ASCENDING-DOSE STUDY OF THE PHARMACOKINETICS AND SAFETY OF LY3154207, A CENTRALLY-ACTING DOPAMINE D1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR (D1 PAM), IN HEALTHY SUBJECTS

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 15; no. 7; pp. P254 - P255
Main Authors Biglan, Kevin, Svensson, Kjell A., Wilbraham, Darren, Tsai, Max, Kielbasa, William
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.07.2019
Online AccessGet full text

Cover

More Information
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2019.06.082